Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.
about
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season.Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh.Influenza vaccines: Evaluation of the safety profile.
P2860
Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@ast
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@en
type
label
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@ast
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@en
prefLabel
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@ast
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@en
P2093
P2860
P50
P356
P1476
Safety and Immunogenicity of F ...... en 6 Through 35 Months of Age.
@en
P2093
Allison Ross Eckard
Andrea A Berry
David I Bernstein
Edwin L Anderson
Heather Hill
Mark C Wolff
Michael A Gerber
Monica M McNeal
P2860
P304
P356
10.1093/JPIDS/PIU061
P577
2014-06-27T00:00:00Z